Sarcoma News and Research

RSS
Johns Hopkins researchers identify new therapy to treat lung cancer

Johns Hopkins researchers identify new therapy to treat lung cancer

CASI Pharmaceuticals reports net loss of $1.8 million for first quarter 2015

CASI Pharmaceuticals reports net loss of $1.8 million for first quarter 2015

Study evaluates VolitionRx's proprietary Nucleosomics platform in most prevalent cancers

Study evaluates VolitionRx's proprietary Nucleosomics platform in most prevalent cancers

Merck KGaA, Darmstadt, Germany granted FDA Fast Track designation for development of evofosfamide

Merck KGaA, Darmstadt, Germany granted FDA Fast Track designation for development of evofosfamide

MabVax closes $11.6 million in private placement

MabVax closes $11.6 million in private placement

Pyrexar Medical procures hyperthermia assets of BSD Medical, begins operations

Pyrexar Medical procures hyperthermia assets of BSD Medical, begins operations

CASI receives CFDA approval for ENMD-2076 Phase 2 clinical trial in ovarian clear cell carcinoma

CASI receives CFDA approval for ENMD-2076 Phase 2 clinical trial in ovarian clear cell carcinoma

CASI initiates ENMD-2076 Phase 2 trial in Chinese patients with triple-negative breast cancer

CASI initiates ENMD-2076 Phase 2 trial in Chinese patients with triple-negative breast cancer

Study reveals functional heterogeneity of CD4 T cells in immune systems

Study reveals functional heterogeneity of CD4 T cells in immune systems

Study shows efficacy of YONDELIS (trabectedin) in patients with soft-tissue sarcoma

Study shows efficacy of YONDELIS (trabectedin) in patients with soft-tissue sarcoma

U of T Scarborough professor develops new compound that can lead to cheaper anti-cancer drugs

U of T Scarborough professor develops new compound that can lead to cheaper anti-cancer drugs

Scientists discover DNA vaccine that alleviates chronic inflammation in the body

Scientists discover DNA vaccine that alleviates chronic inflammation in the body

New NCCN Guidelines for treating Acute Lymphoblastic Leukemia

New NCCN Guidelines for treating Acute Lymphoblastic Leukemia

Study: Risk of uterine sarcoma fairly low in women following hysterectomy

Study: Risk of uterine sarcoma fairly low in women following hysterectomy

Facts about precision medicine

Facts about precision medicine

NanoSmart's ANA-conjugated liposomal doxorubicin receives FDA Orphan Drug Designation

NanoSmart's ANA-conjugated liposomal doxorubicin receives FDA Orphan Drug Designation

Research findings could lead to new standard of care for soft tissue sarcomas

Research findings could lead to new standard of care for soft tissue sarcomas

Study could lead to potential therapeutic targets to treat Ewing Sarcoma

Study could lead to potential therapeutic targets to treat Ewing Sarcoma

Janssen granted Priority Review from FDA for YONDELIS (trabectedin) NDA to treat STS patients

Janssen granted Priority Review from FDA for YONDELIS (trabectedin) NDA to treat STS patients

Inhibition of SIRT1 protein may hold promise for treatment of metastatic Ewing sarcoma

Inhibition of SIRT1 protein may hold promise for treatment of metastatic Ewing sarcoma